The investing world has certainly changed in recent decades. If I had proposed to my partners at my former firm in the 1990s that one day we could buy stock in a company that grows marijuana, I would have been fired on the spot. Canadian based Sundial Growers (NASDAQ:SNDL) is just one of the many
The future’s cars have long since moved from our imagination into the real world. High-profile successes and failures have created a polarized discussion surrounding the industry’s outlook, but no conclusions have emerged. As more automakers contemplate the direction of the industry, there are still too many unanswered questions. For one, companies continue to focus exclusively on
It has been quite a year for Robinhood users. Due to the pandemic, usage of the popular trading app (which is privately owned right now but is preparing for an initial public offering targeted for July 29) skyrocketed among amateur investors. Most of them did not have a lot of experience. But they did have
Mark “Forger” Stucky, after piloting the company’s first successful spaceflight on December 13, 2018. Virgin Galactic Mark “Forger” Stucky, Virgin Galactic‘s flight test director and pilot, is no longer with the space tourism company. “I am now a former Director of Flight Test and former SpaceShipTwo pilot,” Stucky wrote in a post on LinkedIn. He
In this article DHI LVS LUV NTGR UNP Blackstone Group office in Luxembourg. Geert Vanden Wijngaert | Bloomberg | Getty Images Check out the companies making headlines in midday trading. DiDi – The Chinese ride-hailing giant’s shares shed more than 9% after Bloomberg News reported that Beijing is considering harsh penalties from a massive fine
In the rosiest of scenarios for Ocugen (NASDAQ:OCGN) stock, the Covaxin vaccine for the novel coronavirus will be approved by the FDA only around the second quarter of 2023. And the company appears to be dragging its feet on getting the process started. Source: shutterstock.com/PhotobyTawat Meanwhile, information I recently uncovered suggests that Canada will probably
Stick around in the business of assessing investment opportunities, and you’re bound to make your fair share of calls that go awry. That’s exactly what happened with my early June take on Vaxart (NASDAQ:VXRT). While I appreciated the company’s distinct approach toward a Covid-19 vaccine, I felt it was doing too little, too late. Therefore,
As all eyeballs focus on the remarkable record-breaking ascent of the major indices, less attention is paid on defensive names. That’s only natural because of immediacy bias or the tendency to perceive current emotions as more intense than previous emotions. Nevertheless, it might be time to think about hedging against this soaring valuation and what
Online brokerage pioneer Thomas Peterffy told CNBC on Wednesday he’s invested in cryptocurrencies, while still expressing skepticism over the long-term future of the digital asset class. “Even I myself have put a little bit of money into crypto, because even though chances are, I think, that this is not going to be a viable market,
In this article CSX KMI TXN LVS Signage is displayed outside the Venetian Resort in Las Vegas, Nevada, U.S., on Sunday, Oct. 18, 2020. Roger Kisby | Bloomberg | Getty Images Check out the companies making headlines in after-hours trading. Las Vegas Sands — Shares of the casino giant slipped 2% in extended trading after
While even former dogs like Ford Motor (NYSE:F) have gotten expensive of late, JPMorgan Chase (NYSE:JPM) stock remains dirt cheap. Source: Roman Tiraspolsky / Shutterstock.com America’s biggest bank opened July 14 at $149.71 per share. That’s a market cap of $447 billion, which sounds massive. But it’s also a price-to-earnings ratio of just 10. There’s
Health insurance company Clover Health (NASDAQ:CLOV) is on a mission to lower costs for Medicare patients. So far, it is spending more money than it brings in. Additionally, activist short-seller Hindenburg Research released a scathing report that criticizes its business model and the quality of its software. As a result, CLOV stock is incredibly volatile
To make a comparison to football, IBM (NYSE:IBM) is the Dallas Cowboys of technology. How do I mean? Well, both IBM and the Cowboys are overrated. They haven’t won a title in a quarter century and they’re not going to do it this year. Their system is stale, yet somehow they still have fans. All
Many businesses offer some form of qualified retirement plan and, in doing so, they fall under the governance guidelines of the Employee Retirement Income Security Act of 1974, better known as ERISA. ERISA establishes guidelines and minimum standards designed to protect employees of private sector companies who participate in retirement and welfare benefit plans. Businesses
While Elon Musk continues playing with Dogecoin (CCC:DOGE-USD), investors continue to lose money. Down 14% over the past seven days, it’s clear that cryptocurrencies including DOGE-USD are in for one heck of a bear market. When will it end? Who knows. For those who merely want to make money from their investments, here are three
In this article HAL RUN NOVA VZ NFLX CMG Customers wait outside of a Chipotle restaurant as they wait to enter in order to place an order as Florida continues with its Phase 1 of reopening the state during the Coronavirus (COVID-19) pandemic on May 19, 2020, in Aventura, FL. Icon Sportswire | Getty Images
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue-chip stocks that have proven to reward shareholders with rising dividends over a long period. While historic dividend payment does not guarantee future distributions, it can help investors when accessing the likelihood of a
Many may be waiting for the other shoe to drop with Gamestop (NYSE:GME) stock. But not even market-wide jitters about the Delta variant could knock down the most popular “meme stock.” In fact, on the day the Dow slumped over concerns, GME stock ticked higher rather than lower. Source: Emil O / Shutterstock.com Will this
Canopy Growth (NASDAQ:CGC) and CGC stock lost ground in recent days due to the realization by investors that the new cannabis legalization bill being put forward by Senate Majority Leader Chuck Schumer has got a long way to go before it goes to a vote. Source: Shutterstock When it does, it’s doomed to fail.
Defensive stocks, which typically have low market risk, are getting increased attention. And these types of shares are popular because they can help protect portfolios from rapid market declines or wild swings in returns. Today, I’ll introduce seven defensive stocks to buy for the earnings season. Despite stomach-churning volatility, especially in the early days of the